Correlation Between Clearmind Medicine and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Clearmind Medicine and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clearmind Medicine and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Clearmind Medicine Common and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Clearmind Medicine and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clearmind Medicine with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clearmind Medicine and Sonnet Biotherapeutics.

Diversification Opportunities for Clearmind Medicine and Sonnet Biotherapeutics

0.46

Correlation Coefficient

Clearmind Medicine  Sonnet Biotherapeutics

Very weak diversification

The 3 months correlation between Clearmind and Sonnet is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Clearmind Medicine Common and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Clearmind Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clearmind Medicine Common are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Clearmind Medicine i.e., Clearmind Medicine and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Clearmind Medicine and Sonnet Biotherapeutics

Given the investment horizon of 90 days Clearmind Medicine is expected to generate 1.28 times less return on investment than Sonnet Biotherapeutics. In addition to that, Clearmind Medicine is 1.13 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.02 of its total potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about 0.02 per unit of volatility. If you would invest  144.00  in Sonnet Biotherapeutics Holdings on December 21, 2024 and sell it today you would lose (1.00) from holding Sonnet Biotherapeutics Holdings or give up 0.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Clearmind Medicine Common  vs.  Sonnet Biotherapeutics Holding

Clearmind Medicine Common

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Clearmind Medicine Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearmind Medicine may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Sonnet Biotherapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Clearmind Medicine and Sonnet Biotherapeutics

The main advantage of trading using opposite Clearmind Medicine and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clearmind Medicine position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Clearmind Medicine Common and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.